Zobrazeno 1 - 5
of 5
pro vyhledávání: '"B Ted, Hall"'
Autor:
James F. Cummings, Birgitte Giersing, W. Ripley Ballou, David E. Lanar, Elissa Malkin, Christian F. Ockenhouse, Kathryn Tucker, Filip Dubovsky, V. Ann Stewart, Mark E. Polhemus, Robin K. Nielsen, Megan Dowler, Marie-Claude Dubois, D. Gray Heppner, Robert Schwenk, Joe Cohen, Jack Williams, Laure Y. Juompan, Collette J. Hillier, Christine Prosperi, Kent E. Kester, Lisa A. Ware, Douglas S. Walsh, In-Kyu Yoon, B. Ted Hall, Urszula Krzych, Michele D. Spring
Publikováno v:
Vaccine. 28:5135-5144
Plasmodium falciparum Liver Stage Antigen 1 (LSA-1) is a pre-erythrocytic stage antigen. Our LSA-1 vaccine candidate is a recombinant protein with full-length C- and N-terminal flanking domains and two of the 17 amino acid repeats from the central re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e10eb21d2d3990dda9655444fa522891
https://doi.org/10.1016/j.vaccine.2009.08.046
https://doi.org/10.1016/j.vaccine.2009.08.046
Autor:
Kent E, Kester, James F, Cummings, Christian F, Ockenhouse, Robin, Nielsen, B Ted, Hall, Daniel M, Gordon, Robert J, Schwenk, Urszula, Krzych, Carolyn A, Holland, Gregory, Richmond, Megan G, Dowler, Jackie, Williams, Robert A, Wirtz, Nadia, Tornieporth, Laurence, Vigneron, Martine, Delchambre, Marie-Ange, Demoitie, W Ripley, Ballou, Joe, Cohen, D Gray, Heppner, Steve, Fitzpatrick
Publikováno v:
Vaccine. 26(18)
Summary Background Immunization with RTS,S/AS02 consistently protects some vaccinees against malaria infection in experimental challenges and in field trials. A brief immunization schedule against falciparum malaria would be compatible with the Expan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405ce9af65d86746e47c0aa3cbbda6fd
https://pubmed.ncbi.nlm.nih.gov/18387719
https://pubmed.ncbi.nlm.nih.gov/18387719
Publikováno v:
Comparative medicine. 57(4)
To determine whether antibodies to the 19-kDa fragment of merozoite surface protein 1 (MSP1(19)) help to control blood-stage Plasmodium falciparum infection, we performed a rechallenge experiment of previously infected Aotus monkeys. Monkeys previous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d8c667781452f4ae9ef647daf21e6e38
https://pubmed.ncbi.nlm.nih.gov/17803055
https://pubmed.ncbi.nlm.nih.gov/17803055
Autor:
Arnoldo Barbosa, Urszula Krzych, Montip Gettyacamin, Janet Wittes, Sheetij Dutta, Lorraine Soisson, Nathalie Garçon, Patrice M. Dubois, Nadia Tornieporth, Mahamadou A. Thera, Christian A. Darko, Kathryn Tucker, B. Ted Hall, V. Ann Stewart, Bernhards Ogutu, Ogobara K. Duombo, Marie-Claude Dubois, Opokua Ofori, Lisa A. Ware, Jessica Milman, Jeffrey A. Lyon, W. Ripley Ballou, Mark E. Polhemus, Amanda J. Leach, Christopher V. Plowe, Evelina Angov, Philippe Moris, Jaap Goudsmit, Robert Schwenk, D. Gray Heppner, Maria G. Pau, Lalitha Nair, Collette J. Hillier, James F. Cummings, Mark M. Fukuda, David E. Lanar, Joe Cohen, Kent E. Kester, Christian F. Ockenhouse, Sathit Pichyangkul, Carter L. Diggs, Mark R. Withers
Publikováno v:
Vaccine, 23(17-18), 2243-2250. Elsevier BV
The goal of the Malaria Vaccine Program at the Walter Reed Army Institute of Research (WRAIR) is to develop a licensed multi-antigen, multi-stage vaccine against Plasmodium falciparum able to prevent all symptomatic manifestations of malaria by preve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d974e943c48c68630a6b69f206b51f41
https://pure.amc.nl/en/publications/towards-an-rtssbased-multistage-multiantigen-vaccine-against-falciparum-malaria-progress-at-the-walter-reed-army-institute-of-research(b29e56f8-c0e6-4c93-81d0-5a5fcce364e9).html
https://pure.amc.nl/en/publications/towards-an-rtssbased-multistage-multiantigen-vaccine-against-falciparum-malaria-progress-at-the-walter-reed-army-institute-of-research(b29e56f8-c0e6-4c93-81d0-5a5fcce364e9).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.